PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies

Clinical trial NCT05003141 · UNKNOWN

Trial details

NCT number: NCT05003141
Sponsor: Qilu Puget Sound Biotherapeutics (dba Sound Biologics)
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Follicular Lymphoma Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Waldenstrom Macroglobulinemia Marginal Zone Lymphoma Mantle Cell Lymphoma Indolent Lymphoma Refractory B-Cell Lymphoma MALT Lymphoma

Start date: 2021-11-15
Primary completion: 2023-07-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.